0001656536-17-000002.txt : 20170113 0001656536-17-000002.hdr.sgml : 20170113 20170113085902 ACCESSION NUMBER: 0001656536-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 EFFECTIVENESS DATE: 20170113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Decibel Therapeutics, Inc. CENTRAL INDEX KEY: 0001656536 IRS NUMBER: 464198709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-250116 FILM NUMBER: 17526583 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 430 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-370-8701 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 430 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0707 D/A LIVE 0001656536 Decibel Therapeutics, Inc. 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 617-370-8701 DELAWARE None None Corporation true 2013 Kevin Starr 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director Steven H. Holtzman 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Craig Muir 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director Jens Eckstein 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director Jeffrey Jonas 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director George Scangos 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director Troy Brennan 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director Roger Brown 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Director John J. Keilty 215 First Street Suite 430 Cambridge MA MASSACHUSETTS 02142 Executive Officer Biotechnology Decline to Disclose 06b true 0001656536-15-000001 2015-10-13 true true false 0 57758734 32332584 25426150 false 3 0 0 0 false Decibel Therapeutics, Inc. /s/ Steven H. Holtzman Steven H. Holtzman Chief Executive Officer 2017-01-13